SEOUL, March 17 (Korea Bizwire) — LG Chem Ltd., South Korea’s leading chemical company, said Monday the accumulated sales of its own diabetes drug have exceeded 1 trillion won (US$688 million) in the domestic market. LG Chem sold a cumulative 1.066 trillion won worth of the Zemiglo diabetes lineup, composed of Zemiglo, Zemimet, Zemidapa and [...]
SEOUL, March 11 (Korea Bizwire) — Individuals with Type 1 diabetes face nearly twice the risk of suicide compared to the general population and 1.8 times higher risk than cancer patients, according to a groundbreaking study published in the Journal of Internal Medicine. The research, conducted by Kim Jae-hyeon, Kim Gyu-ri, and Kim Seohyun from Samsung Seoul [...]
SEOUL, Feb. 3 (Korea Bizwire) — Nearly half of South Korean men in their 20s and 30s are classified as obese, while about 30% of young adults are in the pre-diabetes or pre-hypertension stage, according to a new study highlighting alarming health trends among the country’s younger population. The findings, published in a recent issue [...]
SEOUL, Jan. 8 (Korea Bizwire) — A new study has revealed significant regional disparities in access to diabetic care across South Korea, with some Seoul districts having nearly six times better accessibility than rural areas, as the number of people with diabetes continues to rise amid an aging population. According to research published in the recent [...]
SEOUL, Nov. 11 (Korea Bizwire) – Diabetes, once primarily associated with older adults, is increasingly affecting younger South Koreans, with an estimated 308,000 people in their 20s and 30s living with the condition, according to new data. The Korean Diabetes Association, ahead of World Diabetes Day on November 14, released its “Diabetes Fact Sheet 2024″ revealing [...]
SEOUL, Oct. 9 (Korea Bizwire) – A new study from South Korea has uncovered a disturbing link between diabetes, economic hardship, and suicide risk, highlighting the urgent need for social attention and practical support for vulnerable patients. The Korean Diabetes Association (KDA) reported on October 8 that low-income individuals with diabetes face a suicide risk 4.34 times [...]
SEOUL, Feb. 22 (Korea Bizwire) – A recent study has revealed that a higher resting heart rate is associated with an increased risk of developing diabetes, a chronic condition. The Korea Disease Control and Prevention Agency reported that the National Institute of Health used data from 8,313 participants aged 40 and above, who took part in [...]
SEOUL, Nov. 14 (Korea Bizwire) – The number of individuals living with diabetes in Korea has surpassed 6 million, with over half of adults requiring diabetes management, including those in the pre-diabetes stage. On Monday, preceding World Diabetes Day (November 14), the Korea Disease Control and Prevention Agency (KDCA) released a report on the current status [...]
SEOUL, Aug. 28 (Korea Bizwire) — There is a strong correlation between income levels and the incidence of diabetes in South Korea, a study showed Sunday. A collaborative research group consisting of the Catholic University Bucheon St. Mary’s Hospital, Soongsil University and Korea University Guro Hospital classified 7.82 million adults aged between 30 and 64, [...]
SEOUL, Aug. 14 (Korea Bizwire) — South Korean pharmaceutical companies, currently involved in developing drugs for diabetes and obesity, are emphasizing the improvement of usage convenience by extending drug efficacy durations and modifying formulations. Peptron Inc. is progressing toward transferring PT404, a sustained-release diabetes and obesity treatment formulation, to global pharmaceutical firms. Unlike existing treatments [...]